Navigation Links
Mr. Tad Ballantyne to Join Mach One Board of Directors

BELGIUM, Wisc., Dec. 1 /PRNewswire-FirstCall/ -- Mach One Corporation (Pink Sheets: MNCN), a biological solutions company that develops products that produce a positive long term benefit to the agricultural and consumer market, announced today that Mr. Tad Ballantyne will join the Company's Board of Directors effective upon the closing of the acquisition of Pacific Rim Foods by Mach One this month.

Mr. Ballantyne is an officer and/or director of a number of public and private companies and is an active participant within each of these companies.

Ballantyne is CEO and director of Hoopeston Foods Inc., a private company engaged in the shelf stable food processing business. Ballantyne is also an officer and director of Thomsen Group LLC a stainless steel equipment business in USA.

In the public sector, Ballantyne is a director and the audit chairman of Life Partners Holdings Inc a public company engaged in the financial services sector whose market value during his tenure has increased from $40 million to over $400 million. Ballantyne is also co-chairman of Zeehan Zinc Ltd. (a London Stock Exchange AIM listed company engaged in the metals and mining sector that recently received shareholder approval to accept a controlling interest from Creat Group -- a private company in China. Ballantyne is also a director of Empire Energy Corporation International a company engaged in the oil & gas sector.

Ballantyne received his degree in Business Management from The University of Wisconsin. Ballantyne has also been involved over the last 20 years in the acquisition and turnaround of troubled subsidiaries of public and private firms. Ballantyne is also an advisor to a number of China based financial services and investment holding companies.

Monte Tobin, President and CEO of Mach One, said, "We are thrilled to have someone with Tad's strong business and financial experience to join our Board. He brings a wealth of business contacts and strategy expertise that will be useful as we continue to execute on our business strategy. I feel that he is the strongest of all the assets being acquired in the Pacific Rim Foods deal."

Safe Harbor Statement

This press release contains forward-looking information. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties which are disclosed in the Company's SEC reports. These risks and uncertainties could cause actual results to differ materially from those currently anticipated or projected. Readers are encouraged to view the Company's risks identified under the caption "Risk Factors" in the S-1 Registration Statement of the Company as Amended filed with the Securities and Exchange Commission on September 18, 2008.

SOURCE Mach One Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases
2. Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the Presidents Council on Physical Fitness and Sports, to Board of Directors
3. Craig A. Norris Appointed to Providence Service Corporation Board of Directors
4. Investor Group Commends Clint Severson for Joining Trinity Biotechs Board of Directors
5. Savients Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
6. MDS Inc. Announces Appointment of James S.A. MacDonald as Chairman of Board of Directors
7. Introducing The Hot Tooth Keyboard, the Cleanable, Hygienic, Wireless Keyboard for Dental Practitioners and Laboratories
8. Consumers Weigh in on Which TV Doc They Would Want as Their Own:Survey Results from the American Board of Medical Specialties Find Dr. House Most Loved/Hated TV Doctor
9. MedVantx(R) Names Newest Board Member
10. Scott T. Williams Elected to the RetireSafe Board of Directors
11. Encorium Appoints Shahab Fatheazam to its Board of Directors
Post Your Comments:
(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: